Top Markets
#1 MowCat MowCat +48.90%
#2 Bermuda Shorts Bermuda Shorts +35.34%
#3 aPriori aPriori +23.54%
#4 Biconomy Biconomy +19.82%
#5 Derive Derive +19.62%
#6 Velvet Velvet +18.18%
#7 Audiera Audiera +17.60%
#8 Quack AI Quack AI +17.21%
#9 Perle Perle +15.57%
#10 Block Street Block Street +12.65%
Coin of the day
MowCat MowCat
Settings
Language
ENGLISH
Currency
USD
Theme
Firebrick Pharma Limited Firebrick Pharma Limited

Firebrick Pharma Limited

FRE
Rank in Stocks #35032
Firebrick Pharma Limited, an enterprise established in 2012 and headquartered... Firebrick Pharma Limited, an enterprise established in 2012 and headquartered in Melbourne, Australia, is dedicated to the research, development, and market launch of Nasodine, a nasal spray treatment for the common cold, exclusively for the Australian market.
Share Price
$0.01904269
Last synced: 2026-08-14
Market Cap
$4.55M
Change (1 day)
0.00%
Change (1 year)
-63.41%
Country
AU
Trade Firebrick Pharma Limited (FRE)

Category

Healthcare
Revenue for Firebrick Pharma Limited (FRE)
Revenue in Aug 2026 TTM: 0
According to Firebrick Pharma Limited latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Firebrick Pharma Limited from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 $79.67B -
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 $97.93B -
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 $64.39B -
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 $77.52B -
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 $66.40B -
US